Dexlansoprazole for Injection(Shenghe (China) Pharma)
注射用右兰索拉唑（南京博德生物）
Report date: 2025/07/18 16:59:40
Base Information
Drug NameDexlansoprazole for Injection(Shenghe (China) Pharma)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2022/11/30
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShenghe (China) Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesShenghe (China) Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A